Abiraterona Qilu

Abiraterone Acetate is a medication used to treat certain types of cancer. This oral medication is manufactured by Qilu Pharma Spain S.L. and is available in the EU market.

Abiraterone Acetate is primarily used in the treatment of prostate cancer. It works by reducing the levels of androgens in the body, which can help slow the growth of cancer cells. This medication is often prescribed as part of a comprehensive treatment plan.

Common effects of Abiraterone Acetate may include fatigue, joint pain, and swelling in the hands or feet. Some users may also experience high blood pressure or changes in liver function. It is important to monitor these effects and consult a healthcare provider if they become severe.

Abiraterone Acetate should be handled with care. It is important to follow the prescribed dosage and administration instructions. This medication may interact with other drugs, so it is advisable to inform your healthcare provider about all medications you are taking. Pregnant women should avoid handling this medication due to potential risks.

Abiraterone Acetate may interact with certain medications, including those that affect liver enzymes. Alcohol consumption should be avoided as it can exacerbate side effects. It is also important to avoid taking this medication with other drugs that can cause liver toxicity.